No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.9x · 10Y median 0.7x · 83rd percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 26
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:02:00.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T14:02:00.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T14:02:00.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T14:02:00.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T14:02:00.566Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T14:02:00.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:02:00.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:02:00.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for IBEX Limited (IBEX) stock was $43.18 as of Oct 6, 2026, 10:00 AM EDT, down 0.35% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +14.2% · 3-year avg +40.2%/yr · 5-year avg +20.6%/yr
IBEX Limited is a global enterprise that specializes in delivering comprehensive, technology-powered solutions designed to manage the entire customer lifecycle for businesses. Their service portfolio is built around three core solutions: ibex Connect: This customer engagement platform covers vital services such as customer care, technical assistance, revenue generation initiatives, and other outsourced back-office functions.
Information Technology Services · Washington, DC
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
0.90
Revenue Est.
$169.31M
Last Quarter Results
EPS
$0.85
vs Estimate
$0.84
Revenue
$164.27M
vs Estimate
$160.02M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1IBEX | $578.14M | $43.18 | -0.35% | +14.19% | +20.64% | N/A | N/A |
| 2ADTN | $586.43M | $7.24 | +1.26% | -22.61% | -16.69% | -7.94% | vs IBEX |
| 3MEI | $555.49M | $15.66 | +1.69% | +92.97% | -16.32% | -6.17% | vs IBEX |
| 4DCBO | $613.24M | $24.16 | +2.03% | -13.64% | -19.64% | N/A | vs IBEX |
| 5INDI | $620.13M | $2.94 | +0.86% | -31.88% | -24.23% | N/A | vs IBEX |
| 6CLMB | $628.68M | $33.69 | -0.12% | -3.46% | +39.44% | +25.28% | vs IBEX |
3.40
Consensus Rating
Based on 2 analysts
Average Price Target
$42.00
-2.7% downside
Low
$40.00
Current
$43.18
High
$44.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.89 | $0.90 | $0.91 | 2 |
| Quarter ending Dec 2026 | $0.89 | $0.91 | $0.93 | 2 |
| Quarter ending Mar 2027 | $0.96 | $0.97 | $0.98 | 1 |
| Quarter ending Jun 2027 | $0.91 | $0.92 | $0.93 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $3.68 | $3.70 | $3.72 | 2 |
| FY 2028 | $3.99 | $4.08 | $4.18 | 2 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $169.30M | $169.31M | $169.32M | 2 |
| Quarter ending Dec 2026 | $180.64M | $181.47M | $182.30M | 2 |
| Quarter ending Mar 2027 | $180.00M | $180.82M | $181.65M | 1 |
| Quarter ending Jun 2027 | $179.87M | $180.70M | $181.52M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Jun 30, 2027, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $711.51M | $712.30M | $713.10M | 2 |
| FY 2028 | $759.51M | $760.40M | $761.30M | 2 |
